On March 18th, 2022, Venus Medtech (Hangzhou) Inc. announced the appointment of Shakeel Osman as Senior Vice President of Sales Europe, responsible for the commercialization of congenital heart devices. At present, the company's transcatheter pulmonic valve replacement (TPVR) system VenusP-Valve designed for congenital heart disease patients is awaiting CE mark approval. Prior to joining Venus Medtech, Shakeel Osman served as General Manager UK & Vice President Sales Middle East Asia and Africa at Occlutech Medical Devices.